Director Stock Option Grant for Kathleen Goetz at Aurinia Pharmaceuticals Inc.

Kathleen Goetz, a director at Aurinia Pharmaceuticals Inc. (AUPH), was granted a Director Stock Option on June 4, 2026. The option, which represents the right to buy common shares, has an exercise price of $15.67 per share and an expiration date of June 4, 2036. The option vests one year from the date of grant. Ms. Goetz acquired 23,931 shares through this option, bringing her total post-transaction shares to 23,931. The transaction was reported on June 8, 2026.